Hyperinsulinism due to glutamodehydrogenase deficiency

Hyperinsulinism due to Glutamate Dehydrogenase Deficiency is a rare genetic disorder characterized by an excessive secretion of insulin due to mutations affecting the enzyme glutamate dehydrogenase. This condition falls under the broader category of hyperinsulinemic hypoglycemia, a group of genetic or acquired metabolic disorders that result in the inappropriate secretion of insulin from the pancreas, leading to low blood sugar levels (hypoglycemia).

Causes

Hyperinsulinism due to Glutamate Dehydrogenase Deficiency is caused by mutations in the GLUD1 gene, which encodes the enzyme glutamate dehydrogenase. This enzyme plays a crucial role in amino acid metabolism and energy production within cells, particularly in the liver and pancreas. Mutations in the GLUD1 gene lead to a gain of function, increasing the enzyme's activity, which in turn causes excessive insulin secretion in response to protein intake or other metabolic signals.

Symptoms

The primary symptom of this condition is recurrent episodes of hypoglycemia, which can manifest as sweating, irritability, confusion, dizziness, or even seizures and loss of consciousness if left untreated. These symptoms typically occur during fasting or after protein-rich meals. Chronic hypoglycemia can lead to long-term complications, including neurological damage and developmental delays in children.

Diagnosis

Diagnosis of Hyperinsulinism due to Glutamate Dehydrogenase Deficiency involves a combination of clinical evaluation, biochemical tests, and genetic testing. Biochemical tests may show elevated levels of ammonia in the blood, along with hypoglycemia and high insulin levels. Genetic testing is used to confirm the presence of mutations in the GLUD1 gene.

Treatment

Treatment aims to manage hypoglycemia and prevent its complications. Dietary management, including frequent carbohydrate-rich meals and avoidance of fasting, is often recommended. In some cases, medications that suppress insulin secretion, such as diazoxide, may be used. Severe cases may require surgical intervention to remove a portion of the pancreas (partial pancreatectomy).

Prognosis

The prognosis for individuals with Hyperinsulinism due to Glutamate Dehydrogenase Deficiency varies. With early diagnosis and appropriate management, many individuals can lead normal lives, although they may require ongoing monitoring and treatment to prevent hypoglycemic episodes. However, without proper management, there is a risk of serious complications, including permanent neurological damage.

This metabolic pathology related article is a stub. You can help WikiMD by expanding it.